Uncoupling of disease activity and structural damage. Does it matter clinically?
Identifieur interne : 002835 ( Main/Exploration ); précédent : 002834; suivant : 002836Uncoupling of disease activity and structural damage. Does it matter clinically?
Auteurs : Edith Villeneuve [Canada] ; Boulos Haraoui [Canada]Source :
- Annals of the Rheumatic Diseases [ 0003-4967 ] ; 2013-01.
English descriptors
- Teeft :
- Aletaha, Antirheumatic drugs, Arthritis, Arthritis rheum, Arthritis rheum emery, Arthritis rheum smolen, Biologic agents, Biologics, Bone damage, Bone erosion, Bone marrow, Bone marrow aggregates, Bone marrow oedema, Boulos haraoui, Clinical improvement, Disease activity, Heijde, Joint damage, Joint space, Methotrexate, Methotrexate retards, Methotrexate therapy, Oedema, Progression, Radiographic, Radiographic outcomes, Radiographic progression, Remission, Rheum, Rheumatoid, Rheumatoid arthritis, Rheumatoid arthritis patients, Rituximab, Smolen, Structural damage, Subchondral bone, Synovial, Synovial tissue.
Url:
DOI: 10.1136/annrheumdis-2012-202650
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000B80
- to stream Istex, to step Curation: 000B80
- to stream Istex, to step Checkpoint: 000326
- to stream Main, to step Merge: 002849
- to stream Main, to step Curation: 002835
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Uncoupling of disease activity and structural damage. Does it matter clinically?</title>
<author><name sortKey="Villeneuve, Edith" sort="Villeneuve, Edith" uniqKey="Villeneuve E" first="Edith" last="Villeneuve">Edith Villeneuve</name>
</author>
<author><name sortKey="Haraoui, Boulos" sort="Haraoui, Boulos" uniqKey="Haraoui B" first="Boulos" last="Haraoui">Boulos Haraoui</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:04B601D760CDE24B278F083E68229314B1D525C7</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1136/annrheumdis-2012-202650</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-B6KH9HBB-6/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B80</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B80</idno>
<idno type="wicri:Area/Istex/Curation">000B80</idno>
<idno type="wicri:Area/Istex/Checkpoint">000326</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000326</idno>
<idno type="wicri:doubleKey">0003-4967:2013:Villeneuve E:uncoupling:of:disease</idno>
<idno type="wicri:Area/Main/Merge">002849</idno>
<idno type="wicri:Area/Main/Curation">002835</idno>
<idno type="wicri:Area/Main/Exploration">002835</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Uncoupling of disease activity and structural damage. Does it matter clinically?</title>
<author><name sortKey="Villeneuve, Edith" sort="Villeneuve, Edith" uniqKey="Villeneuve E" first="Edith" last="Villeneuve">Edith Villeneuve</name>
<affiliation wicri:level="3"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Rheumatology, Université de Montréal, Montreal</wicri:regionArea>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Haraoui, Boulos" sort="Haraoui, Boulos" uniqKey="Haraoui B" first="Boulos" last="Haraoui">Boulos Haraoui</name>
<affiliation wicri:level="3"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Rheumatology, Université de Montréal, Montreal</wicri:regionArea>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint><publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="2013-01">2013-01</date>
<biblScope unit="volume">72</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="1">1</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Aletaha</term>
<term>Antirheumatic drugs</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Arthritis rheum emery</term>
<term>Arthritis rheum smolen</term>
<term>Biologic agents</term>
<term>Biologics</term>
<term>Bone damage</term>
<term>Bone erosion</term>
<term>Bone marrow</term>
<term>Bone marrow aggregates</term>
<term>Bone marrow oedema</term>
<term>Boulos haraoui</term>
<term>Clinical improvement</term>
<term>Disease activity</term>
<term>Heijde</term>
<term>Joint damage</term>
<term>Joint space</term>
<term>Methotrexate</term>
<term>Methotrexate retards</term>
<term>Methotrexate therapy</term>
<term>Oedema</term>
<term>Progression</term>
<term>Radiographic</term>
<term>Radiographic outcomes</term>
<term>Radiographic progression</term>
<term>Remission</term>
<term>Rheum</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatoid arthritis patients</term>
<term>Rituximab</term>
<term>Smolen</term>
<term>Structural damage</term>
<term>Subchondral bone</term>
<term>Synovial</term>
<term>Synovial tissue</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Québec</li>
</region>
<settlement><li>Montréal</li>
</settlement>
</list>
<tree><country name="Canada"><region name="Québec"><name sortKey="Villeneuve, Edith" sort="Villeneuve, Edith" uniqKey="Villeneuve E" first="Edith" last="Villeneuve">Edith Villeneuve</name>
</region>
<name sortKey="Haraoui, Boulos" sort="Haraoui, Boulos" uniqKey="Haraoui B" first="Boulos" last="Haraoui">Boulos Haraoui</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002835 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002835 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= TocilizumabV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:04B601D760CDE24B278F083E68229314B1D525C7 |texte= Uncoupling of disease activity and structural damage. Does it matter clinically? }}
This area was generated with Dilib version V0.6.34. |